161 related articles for article (PubMed ID: 28301051)
1. Adverse events of cryopreserved hematopoietic stem cell infusions in adults: a single-center observational study.
Otrock ZK; Sempek DS; Carey S; Grossman BJ
Transfusion; 2017 Jun; 57(6):1522-1526. PubMed ID: 28301051
[TBL] [Abstract][Full Text] [Related]
2. The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells.
Ozdemir E; Akgedik K; Akdogan S; Kansu E
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1425-8. PubMed ID: 19041066
[TBL] [Abstract][Full Text] [Related]
3. Infusion technique of hematopoietic progenitor cells and related adverse events (CME).
Mulay SB; Greiner CW; Mohr A; Bryant SC; Lingineni RK; Padley D; Hogan WJ; Gastineau DA; Jacob EK
Transfusion; 2014 Aug; 54(8):1997-2003; quiz 1996. PubMed ID: 24697759
[TBL] [Abstract][Full Text] [Related]
4. Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product.
Calmels B; Lemarié C; Esterni B; Malugani C; Charbonnier A; Coso D; de Colella JM; Deconinck E; Caillot D; Viret F; Ladaique P; Lapierre V; Chabannon C
Transfusion; 2007 Jul; 47(7):1268-75. PubMed ID: 17581163
[TBL] [Abstract][Full Text] [Related]
5. Clinical toxicity of cryopreserved circulating progenitor cells infusion.
Zambelli A; Poggi G; Da Prada G; Pedrazzoli P; Cuomo A; Miotti D; Perotti C; Preti P; Robustelli della Cuna G
Anticancer Res; 1998; 18(6B):4705-8. PubMed ID: 9891544
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic cell infusion-related adverse events in pediatric/small recipients in a prospective/multicenter study.
Ikeda K; Ohto H; Yamada-Fujiwara M; Okuyama Y; Fujiwara SI; Muroi K; Mori T; Kasama K; Kanamori H; Iseki T; Nagamura-Inoue T; Kameda K; Kanda J; Nagai K; Fujii N; Ashida T; Hirose A; Takahashi T; Minakawa K; Tanosaki R
Transfusion; 2020 May; 60(5):1015-1023. PubMed ID: 32306410
[TBL] [Abstract][Full Text] [Related]
7. Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide.
Morris C; de Wreede L; Scholten M; Brand R; van Biezen A; Sureda A; Dickmeiss E; Trneny M; Apperley J; Chiusolo P; van Imhoff GW; Lenhoff S; Martinelli G; Hentrich M; Pabst T; Onida F; Quinn M; Kroger N; de Witte T; Ruutu T;
Transfusion; 2014 Oct; 54(10):2514-22. PubMed ID: 24964911
[TBL] [Abstract][Full Text] [Related]
8. An automatic wash method for dimethyl sulfoxide removal in autologous hematopoietic stem cell transplantation decreases the adverse effects related to infusion.
Sánchez-Salinas A; Cabañas-Perianes V; Blanquer M; Majado MJ; Insausti CL; Monserrat J; Sánchez-Ibáñez MV; Menchón P; García-Hernández A; Gómez-Espuch J; Morales A; Moraleda JM
Transfusion; 2012 Nov; 52(11):2382-6. PubMed ID: 22404870
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients -- impact of cryopreservation with dimethylsulfoxide.
Horacek JM; Jebavy L; Jakl M; Zak P; Mericka P; Maly J
Exp Oncol; 2009 Jun; 31(2):121-2. PubMed ID: 19550404
[TBL] [Abstract][Full Text] [Related]
10. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
[TBL] [Abstract][Full Text] [Related]
11. Washing transplants with Sepax 2 reduces the incidence of side effects associated with autologous transplantation and increases patients' comfort.
Huvarová L; Kořístek Z; Jelínek T; Černá L; Smejkalová J; Navrátil M; Grebeníček L; Tvrdá I; Michalíková M; Hájek R
Transfusion; 2021 Aug; 61(8):2430-2438. PubMed ID: 34197635
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion.
Shu Z; Heimfeld S; Gao D
Bone Marrow Transplant; 2014 Apr; 49(4):469-76. PubMed ID: 24076548
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
[TBL] [Abstract][Full Text] [Related]
14. Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age.
Milone G; Mercurio S; Strano A; Leotta S; Pinto V; Battiato K; Coppoletta S; Murgano P; Farsaci B; Privitera A; Giustolisi R
Cytotherapy; 2007; 9(4):348-55. PubMed ID: 17573610
[TBL] [Abstract][Full Text] [Related]
15. Impact of lower concentrations of dimethyl sulfoxide on cryopreservation of autologous hematopoietic stem cells: a systematic review and meta-analysis of controlled clinical studies.
Bennett B; Hanotaux J; Pasala AR; Hasan T; Hassan D; Shor R; Allan DS; Maganti HB
Cytotherapy; 2024 May; 26(5):482-489. PubMed ID: 38416086
[TBL] [Abstract][Full Text] [Related]
16. A faster reconstitution of hematopoiesis after autologous transplantation of hematopoietic cells cryopreserved in 7.5% dimethyl sulfoxide if compared to 10% dimethyl sulfoxide containing medium.
Mitrus I; Smagur A; Giebel S; Gliwinska J; Prokop M; Glowala-Kosinska M; Chwieduk A; Sadus-Wojciechowska M; Tukiendorf A; Holowiecki J
Cryobiology; 2013 Dec; 67(3):327-31. PubMed ID: 24125911
[TBL] [Abstract][Full Text] [Related]
17. Automatic washing of thawed haematopoietic progenitor cell grafts: a preclinical evaluation.
Abonnenc M; Pesse B; Tissot JD; Barelli S; Lion N
Vox Sang; 2017 May; 112(4):367-378. PubMed ID: 28337763
[TBL] [Abstract][Full Text] [Related]
18. Prevention of dimethylsulfoxide-related nausea and vomiting by prophylactic administration of ondansetron for patients receiving autologous cryopreserved peripheral blood stem cells.
Eisenberg S; Wickline M; Linenberger M; Gooley T; Holmberg L
Oncol Nurs Forum; 2013 May; 40(3):285-92. PubMed ID: 23615140
[TBL] [Abstract][Full Text] [Related]
19. Patients experienced serious adverse reactions within one hour of hematopoietic stem-cell infusion.
Meric N; Parmaksız A; Gulbas Z
Transfus Clin Biol; 2023 Feb; 30(1):82-86. PubMed ID: 35987476
[TBL] [Abstract][Full Text] [Related]
20. Ischemic stroke associated with the infusion of DMSO-cryopreserved auto-PBSCs.
González-López TJ; Sánchez-Guijo FM; Ortín A; Crusoe E; Cordoba I; Corral M; Vazquez L; Caballero MD
Bone Marrow Transplant; 2011 Jul; 46(7):1035-6. PubMed ID: 20956954
[No Abstract] [Full Text] [Related]
[Next] [New Search]
